Shockwave Medical Acquires Neovasc
January 17, 2023
Shockwave Medical, a U.S.-based cardiovascular device company, agreed to acquire Canada-based Neovasc for approximately $100 million upfront plus a contingent value right of up to $12 per share tied to regulatory milestones. The acquisition adds the Neovasc Reducer System for refractory angina to Shockwave’s cardiology portfolio and is expected to close subject to customary conditions and shareholder approval.
- Buyers
- Shockwave Medical, Inc.
- Targets
- Neovasc Inc.
- Industry
- Medical Devices
- Location
- British Columbia, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Johnson & Johnson Acquires Shockwave Medical
April 5, 2024
Medical Devices
Johnson & Johnson will acquire Shockwave Medical for $335.00 per share in an all-cash transaction valued at approximately $13.1 billion including cash acquired. The deal adds Shockwave’s intravascular lithotripsy (IVL) technology to Johnson & Johnson MedTech, expanding J&J’s cardiovascular intervention portfolio and accelerating growth in high‑growth CAD and PAD markets.
-
Johnson & Johnson Completes Acquisition of V‑Wave Ltd.
October 9, 2024
Medical Devices
Johnson & Johnson has completed its acquisition of V‑Wave Ltd., adding V‑Wave’s Ventura Interatrial Shunt to the Johnson & Johnson MedTech portfolio. The transaction was accounted for as an asset acquisition and will result in an in‑process R&D charge of approximately $600 million as J&J expands its cardiovascular and heart‑failure capabilities.
-
Nevro Corp. Acquires Vyrsa Technologies
November 30, 2023
Medical Devices
Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.
-
Abbott Acquires Cardiovascular Systems, Inc.
February 8, 2023
Medical Devices
Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.
-
Boston Scientific Acquires Valencia Technologies
January 12, 2026
Medical Devices
On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.
-
Quantum Surgical Acquires NeuWave Medical
February 27, 2026
Medical Devices
Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.